PSORIATIC ARTHRITIS (PSA)
Clinical trials for PSORIATIC ARTHRITIS (PSA) explained in plain language.
Never miss a new study
Get alerted when new PSORIATIC ARTHRITIS (PSA) trials appear
Sign up with your email to follow new studies for PSORIATIC ARTHRITIS (PSA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-world study confirms upadacitinib's safety in thousands of korean patients
Disease control CompletedThis study looked at the safety and effectiveness of upadacitinib, a drug already approved for rheumatoid arthritis, atopic dermatitis, ankylosing spondylitis, and psoriatic arthritis. About 2,369 Korean adults took the drug as prescribed by their doctor and were followed for 28 …
Matched conditions: PSORIATIC ARTHRITIS (PSA)
Sponsor: AbbVie • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Can a simple supplement ease psoriatic arthritis? new study explores MCTs and fiber
Symptom relief CompletedThis study tested whether a food supplement containing medium-chain triglycerides (MCTs) and vegetable fiber could improve quality of life for people with psoriatic arthritis. 72 adults with low disease activity took the supplement or a placebo for 3 months. The main goal was to …
Matched conditions: PSORIATIC ARTHRITIS (PSA)
Phase: NA • Sponsor: Dr. Schär AG / SPA • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
Massive arthritis drug safety study completed in denmark
Knowledge-focused CompletedThis study looked at the safety of the drug abatacept in over 38,000 people with rheumatoid arthritis or psoriatic arthritis in Denmark. Researchers used a national health database to track rates of different cancers. The goal was to gather more information on the drug's long-ter…
Matched conditions: PSORIATIC ARTHRITIS (PSA)
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC